Barriers to Essential Medicines and Vaccines Persist Across Tanzania’s Hard-to-Reach Communities

Access to essential medicines and vaccines sits at the center of primary care, yet geography, livelihood patterns and health-system reach can make that access uneven long before a patient reaches a clinic. In mainland Tanzania, a qualitative study focused on fisherfolk, artisanal miners and pastoralists—three populations that often move, work far from fixed facilities or live in settings where health infrastructure is thinly spread. The design matters because these communities do not fit neatly into stationary service models built around routine attendance, predictable catchment areas and stable follow-up.

This investigation used perspectives from healthcare professionals and community leaders to examine barriers and strategies related to access. That choice shaped the entire study. Instead of relying on administrative data alone, the researchers used a qualitative exploratory approach to capture contextual factors that are often invisible in supply-chain dashboards or immunization registries. The result is a study built around lived service delivery realities, even though the abstract stops short of presenting patient interviews or a direct account from community members themselves.

A qualitative design is especially useful when the problem is not simply whether medicines exist, but whether people can obtain them at the right time, in the right place, and through systems they trust. For fisherfolk, artisanal miners and pastoralists, the relevant obstacles often extend beyond stock availability. Travel distance, mobility, competing work demands, service timing, and the difficulty of sustaining contact with a fixed facility can all interrupt access to treatment and prevention. For vaccines, those same barriers can become more consequential because missed opportunities for immunization can accumulate silently over time.

Why the Study Design Fits the Public Health Problem

The study’s strength begins with its sampling strategy. Purposive sampling across national, regional, district and community levels allowed the investigators to draw on participants with different roles in health service delivery. In practical terms, this means the analysis was not confined to one administrative level or one viewpoint. National planners may see policy constraints, district actors may see logistics, and community leaders may understand the social realities that determine whether services are actually used.

Triangulation across health-system professionals and community leaders strengthened the credibility of the analysis. So did reflexivity and an audit trail, both of which are important in qualitative work where interpretation must be transparent and defensible. Those methods do not eliminate subjectivity, but they make the reasoning behind the findings more traceable. In a topic as context-dependent as medicine access, that rigor is not optional; it is the mechanism that gives the conclusions weight.

The abstract frames the study as exploratory, which is appropriate for a setting where local barriers are likely layered and specific to occupation, mobility and geography. Fisherfolk may spend long periods near water bodies rather than near clinics. Artisanal miners may work in informal, transient settlements. Pastoralists may move with livestock and may not remain within a single service area long enough for standard appointment systems to function smoothly. These are not minor administrative inconveniences. They are structural barriers that can fragment care, interrupt treatment courses and leave preventive services underused.

What the Study Can and Cannot Claim

One sentence in the limitations section carries particular importance: the study did not include direct interviews with patients or community members. That omission narrows the picture. Healthcare professionals and community leaders can describe access barriers well, but they cannot fully substitute for the voices of people who must decide whether to travel, wait, pay indirect costs or return for follow-up. Lived experience often reveals the friction points that outsiders miss, including perceptions of quality, acceptability and prior disappointments with the health system.

The purposive selection of three regions also limits transferability. Mainland Tanzania is diverse, and access barriers in one region may not map neatly onto another where transport routes, settlement patterns, market structures or health-facility density differ. The study still has value because it does not claim universality. It instead offers context-rich evidence from selected hard-to-reach populations, which is exactly where qualitative inquiry can be most informative.

The absence of direct patient interviews does not invalidate the findings. It does mean the conclusions should be read as a health-system perspective on accessibility rather than a complete map of user experience. For vaccine delivery, that distinction matters because supply-side fixes alone rarely solve underuse. A clinic can be stocked and staffed while still remaining functionally inaccessible if opening hours, outreach schedules or referral pathways do not align with community movement patterns.

Service Delivery Questions Raised by Mobility and Distance

The study’s focus invites a straightforward clinical and operational question: how should primary care adapt when the population does not remain in one place long enough for conventional delivery models to work well? In mobile or semi-mobile communities, access often depends on outreach, flexible scheduling, trusted intermediaries and service points that follow people rather than wait for them to arrive. Essential medicines and vaccines both require that kind of operational realism. Without it, policy goals can remain intact on paper while access continues to erode in practice.

For health systems, the most useful contribution of this study may be its insistence that accessibility is not just a supply issue. It is a relationship among geography, workforce organization, service timing, community trust and the ability of health services to adapt to people whose livelihoods take them away from standard facility-based care. A vaccine sitting in a cold chain and a medicine sitting in a store room do not help if the delivery platform cannot reach the population that needs them.

The abstract does not provide detailed outcome metrics, and it should not be forced into a numerical narrative it never offered. Its value lies elsewhere: in documenting a carefully structured qualitative inquiry into why hard-to-reach groups in mainland Tanzania may still face barriers to the most basic tools of primary healthcare. The next evidentiary step is not a broader generalization from this sample alone, but direct engagement with the people whose access remains hardest to secure.


Reporting by Dr. Sarah Lin, MD, MPH for Medicine World Foundation, with additional data provided by BMJ Open.